Response assessment of novoTTF-100A versus best physician’s choice chemotherapy in recurrent glioblastoma.
Eric Wong
Consultant or Advisory Role - Novocure (U)
Research Funding - Novocure
Edwin Lok
No relevant relationships to disclose
Kenneth D. Swanson
Research Funding - Novocure
Shiva Gautam
No relevant relationships to disclose
Herbert H. Engelhard
Consultant or Advisory Role - Novocure (U)
Frank S. Lieberman
No relevant relationships to disclose
Sophie Taillibert
No relevant relationships to disclose
Zvi Ram
Consultant or Advisory Role - Novocure (U)
Stock Ownership - Novocure
John L. Villano
Consultant or Advisory Role - Novocure (U)